Great-Point-Partners

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "CNTA",
  "ABVX",
  "DVAX",
  "MREO",
  "SMMT",
  "LEGN",
  "NGNE",
  "AKBA",
  "AMLX",
  "AUTL",
  null,
  "KALV",
  "UNCY",
  "IONS",
  "PMN",
  "RZLT",
  "ZURA",
  "UPB",
  "PLRX",
  "ACLX",
  "CNTX",
  "EOLS",
  "VRDN",
  "VYGR",
  "XENE",
  "IMVT",
  "PCVX",
  "BEAM",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 32
Total Value: 188796269
Accession Number: 0001172661-25-002331
Form Type: 13F-HR
CIK: great-point-partners
Manager Name: Great-Point-Partners

Data Enrichment

97% identified

31 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

32 positions • $188.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

G4444H101

Shares:373.8K

Value:$4.2M

% of Portfolio:2.2% ($4.2M/$188.8M)

Zura Bio Ltd

ZURA|G9TY5A101

Shares:3.2M

Value:$4.1M

% of Portfolio:2.2% ($4.1M/$188.8M)

Beam Therapeutics Inc.

BEAM|07373V105

Shares:175.6K

Value:$3.4M

% of Portfolio:1.8% ($3.4M/$188.8M)

Arcellx, Inc.

ACLX|03940C100

Shares:45.0K

Value:$3.0M

% of Portfolio:1.6% ($3.0M/$188.8M)

Mereo BioPharma Group plc

MREO|589492107

Shares:1.3M

Value:$2.9M

% of Portfolio:1.5% ($2.9M/$188.8M)

Context Therapeutics Inc.

CNTX|21077P108

Shares:4.7M

Value:$2.9M

% of Portfolio:1.5% ($2.9M/$188.8M)

Rezolute, Inc.

RZLT|76200L309

Shares:833.0K

Value:$2.4M

% of Portfolio:1.3% ($2.4M/$188.8M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:149.7K

Value:$2.2M

% of Portfolio:1.1% ($2.2M/$188.8M)

Voyager Therapeutics, Inc.

VYGR|92915B106

Shares:626.3K

Value:$2.1M

% of Portfolio:1.1% ($2.1M/$188.8M)

ProMIS Neurosciences Inc.

PMN|74346M406

Shares:2.6M

Value:$1.8M

% of Portfolio:1.0% ($1.8M/$188.8M)

Upstream Bio, Inc.

UPB|91678A107

Shares:300.0K

Value:$1.8M

% of Portfolio:1.0% ($1.8M/$188.8M)

PLIANT THERAPEUTICS, INC.

PLRX|729139105

Shares:850.0K

Value:$1.1M

% of Portfolio:0.6% ($1.1M/$188.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusipG4444H101)✕	373.8K	QoQ -25.23% (-126.2K) YoY -25.23% (-126.2K)	All Managers (Combined)	$4.2M	2.2% ($4.2M/$188.8M)	QoQ -19.53% (-$1.0M) YoY -18.76% (-$975.7K)
Zura Bio Ltd(ZURAcusipG9TY5A101)	3.2M	QoQ 0.00% (-0) YoY +14.95% (-412.5K)	All Managers (Combined)	$4.1M	2.2% ($4.1M/$188.8M)	QoQ -48.40% (-$3.8M) YoY -42.29% (-$3.0M)
Beam Therapeutics Inc.(BEAMcusip07373V105)	175.6K	QoQ NEW(+175.6K) YoY NEW(+175.6K)	All Managers (Combined)	$3.4M	1.8% ($3.4M/$188.8M)	QoQ NEW(+$3.4M) YoY NEW(+$3.4M)
Arcellx, Inc.(ACLXcusip03940C100)	45.0K	QoQ NEW(+45.0K) YoY -85.00% (-255.0K)	All Managers (Combined)	$3.0M	1.6% ($3.0M/$188.8M)	QoQ NEW(+$3.0M) YoY -85.85% (-$17.9M)
Mereo BioPharma Group plc(MREOcusip589492107)	1.3M	QoQ +10.86% (-125.0K) YoY NEW(+1.3M)	All Managers (Combined)	$2.9M	1.5% ($2.9M/$188.8M)	QoQ -28.72% (-$1.2M) YoY NEW(+$2.9M)
Context Therapeutics Inc.(CNTXcusip21077P108)	4.7M	QoQ 0.00% (-0) YoY NEW(+4.7M)	All Managers (Combined)	$2.9M	1.5% ($2.9M/$188.8M)	QoQ -41.71% (-$2.1M) YoY NEW(+$2.9M)
Rezolute, Inc.(RZLTcusip76200L309)	833.0K	QoQ +33.95% (-211.1K) YoY NEW(+833.0K)	All Managers (Combined)	$2.4M	1.3% ($2.4M/$188.8M)	QoQ -20.72% (-$631.5K) YoY NEW(+$2.4M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	149.7K	QoQ NEW(+149.7K) YoY NEW(+149.7K)	All Managers (Combined)	$2.2M	1.1% ($2.2M/$188.8M)	QoQ NEW(+$2.2M) YoY NEW(+$2.2M)
Voyager Therapeutics, Inc.(VYGRcusip92915B106)	626.3K	QoQ -24.24% (-200.5K) YoY NEW(+626.3K)	All Managers (Combined)	$2.1M	1.1% ($2.1M/$188.8M)	QoQ -54.84% (-$2.6M) YoY NEW(+$2.1M)
ProMIS Neurosciences Inc.(PMNcusip74346M406)	2.6M	QoQ 0.00% (-0) YoY NEW(+2.6M)	All Managers (Combined)	$1.8M	1.0% ($1.8M/$188.8M)	QoQ -26.61% (-$667.4K) YoY NEW(+$1.8M)
Upstream Bio, Inc.(UPBcusip91678A107)	300.0K	QoQ 0.00% (-0) YoY NEW(+300.0K)	All Managers (Combined)	$1.8M	1.0% ($1.8M/$188.8M)	QoQ -62.77% (-$3.1M) YoY NEW(+$1.8M)
PLIANT THERAPEUTICS, INC.(PLRXcusip729139105)	850.0K	QoQ -19.43% (-205.0K) YoY -54.10% (-1.0M)	All Managers (Combined)	$1.1M	0.6% ($1.1M/$188.8M)	QoQ -91.74% (-$12.7M) YoY -95.84% (-$26.4M)